Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Cannon

Showing results (401-410 of 467) with videos related to

Pageof 47
Sort By:
Seminars in Arthritis and Rheumatism|April 14, 2023
Enhancing the identification of rheumatoid arthritis-associated interstitial lung disease through text mining of chest computerized tomography reportsBrent A Luedders, Brendan J Cope, Daniel Hershberger, et al.
Open Forum Infectious Diseases|September 21, 2022
Standardization of Epidemiological Surveillance of Group A Streptococcal Cellulitis<sup></sup>Kate M Miller, Theresa Lamagni, Roderick Hay, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 13, 2025
Associations of Fire Smoke and Other Pollutants With Incident Rheumatoid Arthritis and Rheumatoid Arthritis-Associated Interstitial Lung DiseaseVanessa L Kronzer, Yangyuna Yang, Punyasha Roul, et al.
The American Journal of Managed Care|April 16, 2019
Impact of clinical training on recruiting graduating health professionalsSheri A Keitz, David C Aron, Judy L Brannen, et al.
The Lancet. Rheumatology|January 10, 2025
Advanced therapies in US veterans with rheumatoid arthritis-associated interstitial lung disease: a retrospective, active-comparator, new-user, cohort studyBryant R England, Joshua F Baker, Michael D George, et al.
International Immunopharmacology|May 2, 2021
Associations of serum cytokines and chemokines with the risk of incident cancer in a prospective rheumatoid arthritis cohortBryant R England, Megan Campany, Harlan Sayles, et al.
Arthritis and Rheumatism|July 1, 1996
A double-blind, placebo-controlled study of anti-CD5 immunoconjugate in patients with rheumatoid arthritis. The Xoma RA Investigator GroupN J Olsen, R H Brooks, J J Cush, et al.
Seminars in Arthritis and Rheumatism|April 25, 2025
Non-TNFi biologic and targeted synthetic DMARDs in rheumatoid arthritis-associated interstitial lung disease: A propensity score-matched, active-comparator, new-user studyHalie Frideres, Christopher S Wichman, Jianghu Dong, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 15, 2020
Association of Agricultural, Occupational, and Military Inhalants With Autoantibodies and Disease Features in US Veterans With Rheumatoid ArthritisAriadne V Ebel, Gabrielle Lutt, Jill A Poole, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 9, 2026
Performance of the Predicting Risk of Cardiovascular Disease EVENTs (PREVENT) Calculator in Rheumatoid ArthritisTate M Johnson, Halie Frideres, Punyasha Roul, et al.
Pageof 47

Showing results (401-410 of 467) with videos related to

Sort By:
Pageof 47
Seminars in Arthritis and Rheumatism|April 14, 2023
Enhancing the identification of rheumatoid arthritis-associated interstitial lung disease through text mining of chest computerized tomography reportsBrent A Luedders, Brendan J Cope, Daniel Hershberger, et al.
Open Forum Infectious Diseases|September 21, 2022
Standardization of Epidemiological Surveillance of Group A Streptococcal Cellulitis<sup></sup>Kate M Miller, Theresa Lamagni, Roderick Hay, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 13, 2025
Associations of Fire Smoke and Other Pollutants With Incident Rheumatoid Arthritis and Rheumatoid Arthritis-Associated Interstitial Lung DiseaseVanessa L Kronzer, Yangyuna Yang, Punyasha Roul, et al.
The American Journal of Managed Care|April 16, 2019
Impact of clinical training on recruiting graduating health professionalsSheri A Keitz, David C Aron, Judy L Brannen, et al.
The Lancet. Rheumatology|January 10, 2025
Advanced therapies in US veterans with rheumatoid arthritis-associated interstitial lung disease: a retrospective, active-comparator, new-user, cohort studyBryant R England, Joshua F Baker, Michael D George, et al.
International Immunopharmacology|May 2, 2021
Associations of serum cytokines and chemokines with the risk of incident cancer in a prospective rheumatoid arthritis cohortBryant R England, Megan Campany, Harlan Sayles, et al.
Arthritis and Rheumatism|July 1, 1996
A double-blind, placebo-controlled study of anti-CD5 immunoconjugate in patients with rheumatoid arthritis. The Xoma RA Investigator GroupN J Olsen, R H Brooks, J J Cush, et al.
Seminars in Arthritis and Rheumatism|April 25, 2025
Non-TNFi biologic and targeted synthetic DMARDs in rheumatoid arthritis-associated interstitial lung disease: A propensity score-matched, active-comparator, new-user studyHalie Frideres, Christopher S Wichman, Jianghu Dong, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 15, 2020
Association of Agricultural, Occupational, and Military Inhalants With Autoantibodies and Disease Features in US Veterans With Rheumatoid ArthritisAriadne V Ebel, Gabrielle Lutt, Jill A Poole, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 9, 2026
Performance of the Predicting Risk of Cardiovascular Disease EVENTs (PREVENT) Calculator in Rheumatoid ArthritisTate M Johnson, Halie Frideres, Punyasha Roul, et al.
Pageof 47